News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,473 Results
Type
Article (88827)
Company Profile (816)
Press Release (794808)
Multimedia
Podcasts (240)
Webinars (35)
Section
Business (233612)
Career Advice (4163)
Deals (39998)
Drug Delivery (179)
Drug Development (91731)
Employer Resources (207)
FDA (18562)
Job Trends (17490)
News (398780)
Policy (40016)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3054)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (208)
Alliances (56990)
ALS (238)
Alzheimer's disease (1982)
Antibody-drug conjugate (ADC) (561)
Approvals (18918)
Artificial intelligence (890)
ASCO (345)
Autoimmune disease (364)
Automation (66)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (249)
Biotechnology (480)
Bladder cancer (212)
Brain cancer (85)
Breast cancer (841)
Cancer (6644)
Cardiovascular disease (560)
Career advice (3599)
Career pathing (52)
CAR-T (387)
CDC (76)
Celiac Disease (3)
Cell therapy (1081)
Cervical cancer (56)
Clinical research (79139)
Collaboration (2401)
Commercialization (1)
Company closure (8)
Compensation (1537)
Complete response letters (106)
COVID-19 (3043)
CRISPR (126)
C-suite (1305)
Cystic fibrosis (168)
Data (8805)
Decentralized trials (3)
Denatured (92)
Depression (198)
Dermatology (97)
Diabetes (714)
Diagnostics (7610)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (442)
Drug pricing (247)
Drug shortages (39)
Duchenne muscular dystrophy (320)
Earnings (102506)
Editorial (80)
Employer branding (25)
Employer resources (174)
Events (138799)
Executive appointments (1202)
FDA (22682)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1973)
Gene editing (274)
Generative AI (91)
Gene therapy (858)
GLP-1 (1288)
Government (5563)
Grass and pollen (8)
Guidances (421)
Healthcare (21267)
Hematology (198)
HIV (98)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (359)
Immuno-oncology (116)
Indications (213)
Infectious disease (3450)
Inflammatory bowel disease (244)
Inflation Reduction Act (17)
Influenza (153)
Intellectual property (325)
Interviews (822)
IPO (18006)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (123)
Layoffs (690)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (878)
Lymphoma (481)
Machine learning (68)
Management (66)
Manufacturing (1251)
Marketing (1)
MASH (228)
Medical affairs (1)
Medical device (15286)
Medtech (15456)
Mergers & acquisitions (23311)
Metabolic disorders (1843)
mRNA (273)
Multiple sclerosis (207)
NASH (24)
Neurodegenerative disease (518)
Neuropsychiatric disorders (130)
Neuroscience (3758)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5147)
Now hiring (82)
Obesity (876)
Opinion (375)
Ovarian cancer (246)
Pain (286)
Pancreatic cancer (362)
Parkinson's disease (422)
Partnered (41)
Patents (663)
Patient recruitment (772)
Peanut (71)
People (68053)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24458)
Phase 2 (34384)
Phase 3 (25844)
Pipeline (9936)
Policy (400)
Postmarket research (3560)
Preclinical (10994)
Press Release (72)
Prostate cancer (352)
Psychedelics (72)
Radiopharmaceuticals (374)
Rare diseases (1282)
Real estate (7462)
Recruiting (81)
Regulatory (30463)
Reports (77)
Research institute (2772)
Resumes & cover letters (654)
Rett syndrome (43)
RNA editing (30)
RSV (100)
Schizophrenia (197)
Series A (336)
Series B (243)
Service/supplier (28)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4373)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (145)
Vaccines (1317)
Venture capital (137)
Weight loss (600)
Women's health (144)
Worklife (24)
Date
Today (48)
Last 7 days (502)
Last 30 days (2669)
Last 365 days (33223)
2026 (16836)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (406)
Arkansas (16)
Asia (52347)
Australia (9198)
California (14484)
Canada (4046)
China (1595)
Colorado (623)
Connecticut (644)
Delaware (450)
Europe (120714)
Florida (2162)
Georgia (470)
Hawaii (4)
Idaho (70)
Illinois (1265)
India (105)
Indiana (668)
Iowa (26)
Japan (609)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1753)
Massachusetts (10612)
Michigan (427)
Minnesota (807)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3841)
New Mexico (35)
New York (3811)
North Carolina (1947)
North Dakota (11)
Northern California (7202)
Ohio (454)
Oklahoma (27)
Oregon (55)
Pennsylvania (2845)
Puerto Rico (33)
Rhode Island (55)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5690)
Tennessee (232)
Texas (2364)
United States (51848)
Utah (432)
Vermont (2)
Virginia (373)
Washington D.C. (89)
Washington State (1190)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,473 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bionyra Pharma Launches with $165 million Oversubscribed Series A to Advance Clinical Stage Pipeline of Next Generation Biologics for Immune-Mediated Inflammatory Diseases
June 22, 2026
·
7 min read
Press Releases
Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder
June 22, 2026
·
15 min read
Press Releases
Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
June 22, 2026
·
7 min read
Press Releases
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
June 22, 2026
·
17 min read
Press Releases
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test
June 22, 2026
·
6 min read
Neuroscience
UniQure’s chronic epilepsy gene therapy ‘should be on investors’ radar’
As uniQure prepares its closely watched Huntington’s disease gene therapy for FDA review, the biotech is also making waves in chronic epilepsy with another gene therapy that Stifel says is off to a “promising start.”
June 22, 2026
·
3 min read
·
Tristan Manalac
Press Releases
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
June 22, 2026
·
8 min read
Press Releases
Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
June 22, 2026
·
10 min read
Press Releases
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression
June 22, 2026
·
7 min read
Press Releases
TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation
June 22, 2026
·
7 min read
1 of 88,448
Next
